Press Release Archive: 2011 | 2010 | 2009 | 2008 | 2007 | 2005 | View All
Press Releases |
 |
Help us learn more about what it’s like to live with HPP.
> Click here to participate in a survey
Stay Informed
 |
 |
 |
 |
Enobia Expands Clinical Program for ENB-0040, a Bone-targeted Enzyme Replacement Therapy for HypophosphatasiaNovember 02, 2009Enobia Announces Positive Clinical Results with ENB-0040, a Bone Targeted Enzyme Replacement Therapy for HypophosphatasiaSeptember 14, 2009Enobia Raises US$50M from Current Investors in Series C FinancingAugust 10, 2009Enobia Announces Positive Interim Clinical Results with ENB-0040June 11, 2009Enobia Pharma's ENB-0040 receives FDA fast track designationMay 19, 2009Enobia completes target enrollment in clinical trial for infantile HypophosphatasiaMarch 03, 2009